Hansa Biopharma AB (HNSBF)
3.70
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Hansa Biopharma Debt to Equity Ratio : -1.987 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.987 |
| March 31, 2026 | -4.150 |
| December 31, 2025 | -10.55 |
| September 30, 2025 | -1.648 |
| June 30, 2025 | -1.966 |
| March 31, 2025 | -1.628 |
| December 31, 2024 | -1.829 |
| September 30, 2024 | -2.998 |
| June 30, 2024 | -4.454 |
| March 31, 2024 | -2.531 |
| December 31, 2023 | -5.163 |
| September 30, 2023 | -14.95 |
| June 30, 2023 | 4.753 |
| March 31, 2023 | 1.988 |
| December 31, 2022 | 1.312 |
| September 30, 2022 | 2.294 |
| June 30, 2022 | 0.0663 |
| March 31, 2022 | 0.053 |
| December 31, 2021 | 0.0467 |
| September 30, 2021 | 0.0224 |
| June 30, 2021 | 0.0209 |
| March 31, 2021 | 0.0033 |
| December 31, 2020 | 0.0041 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.0047 |
| June 30, 2020 | 0.0196 |
| March 31, 2020 | 0.0181 |
| December 31, 2019 | 0.0168 |
| September 30, 2019 | 0.0167 |
| June 30, 2019 | 0.0162 |
| March 31, 2019 | 0.0182 |
| December 31, 2018 | 0.0015 |
| September 30, 2018 | 0.0023 |
| June 30, 2018 | 0.0012 |
| March 31, 2018 | 0.0011 |
| December 31, 2017 | 0.001 |
| September 30, 2017 | 0.0035 |
| June 30, 2017 | 0.003 |
| March 31, 2017 | 0.0025 |
| December 31, 2016 | 0.0021 |
| September 30, 2016 | 0.0043 |
| June 30, 2016 | 0.0004 |
| March 31, 2016 | 0.0004 |
| December 31, 2015 | 0.0004 |
| September 30, 2015 | 0.0004 |
| June 30, 2015 | 0.0005 |
| March 31, 2015 | 0.1296 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| BioArctic AB | 0.0449 |
| Swedish Orphan Biovitrum AB | 0.4162 |
| Diamyd Medical AB | 0.2051 |
| BONESUPPORT HOLDING AB | 0.0107 |
| BioInvent International AB | 0.0677 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 110.64M |
| Total Liabilities (Quarterly) | 164.40M |
| Shareholders Equity (Quarterly) | -53.75M |
| Current Ratio | 1.246 |
| Net Debt Paydown Yield | -0.38% |